Literature DB >> 31511640

Deubiquitinase Otub1 negatively regulates IL-15 signaling in CD8 T cells and NK cells.

Matthew A Huggins1, Sara E Hamilton2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31511640      PMCID： PMC6828713          DOI： 10.1038/s41423-019-0283-4

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  3 in total

Review 1.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.

Authors:  T A Waldmann; Y Tagaya
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 2.  IL-15 signaling in NK cell cancer immunotherapy.

Authors:  Jai Rautela; Nicholas D Huntington
Journal:  Curr Opin Immunol       Date:  2016-11-11       Impact factor: 7.486

3.  The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming.

Authors:  Xiaofei Zhou; Jiayi Yu; Xuhong Cheng; Baoyu Zhao; Ganiraju C Manyam; Li Zhang; Kimberly Schluns; Pingwei Li; Jing Wang; Shao-Cong Sun
Journal:  Nat Immunol       Date:  2019-06-10       Impact factor: 25.606
  3 in total
  1 in total

Review 1.  New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials.

Authors:  Haoer Jin; Sha Qin; Jiang He; Juxiong Xiao; Qingling Li; Yitao Mao; Luqing Zhao
Journal:  Int J Biol Sci       Date:  2022-03-28       Impact factor: 10.750
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.